Subsidiary Guarantors for Credit Agreement, Term Loan and 2021 Notes (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Jan. 29, 2016	Jan. 30, 2015	Oct. 30, 2015	Jan. 29, 2016	Oct. 30, 2015	Jan. 30, 2015	Oct. 31, 2014
Condensed Consolidating Statement of Income
Net sales	$ 526,300	$ 703,873
Cost of sales	438,256	517,569
Product development, selling and administrative expenses	110,413	130,394
Costs incurred	26,659	665
Other (income) expense, net	(3,941)	(3,213)
Operating (loss) income	(45,087)	58,458
(Loss) income before income taxes	(57,203)	45,501
Provision (benefit) for income taxes	(16,982)	14,976
Net (loss) income	(40,221)	30,525
Comprehensive loss	(72,584)	(86,474)
Current assets:
Cash and cash equivalents	102,885	270,191	$ 270,191	$ 139,933	$ 102,885	$ 152,326	$ 270,191
Accounts receivable, net				650,931	812,073
Inventories				962,663	1,007,925
Other current assets				110,879	145,559
Total current assets				1,864,406	2,068,442
Property, plant and equipment, net				752,448	792,032
Other assets:
Other intangible assets, net				249,678	255,710
Goodwill				354,627	354,621
Deferred income taxes				149,641	118,913
Other non-current assets				109,934	122,728
Total other assets				863,880	851,972
Total assets				3,480,734	3,712,446
Current liabilities:
Short-term borrowings, including current portion of long-term obligations				29,532	26,321
Trade accounts payable				216,408	275,789
Employee compensation and benefits				78,743	90,335
Advance payments and progress billings				235,508	229,470
Accrued warranties				50,518	52,146	58,528	67,272
Other accrued liabilities				211,368	225,277
Current liabilities of discontinued operations				11,582	11,582
Total current liabilities				833,659	910,920
Long-term obligations				992,740	1,060,643
Other liabilities:
Liabilities for postretirement benefits				17,296	19,540
Accrued pension costs				178,513	175,699
Other non-current liabilities				114,108	125,635
Total other liabilities				309,917	320,874
Shareholders’ equity				1,344,418	1,420,009
Total liabilities and shareholders’ equity				3,480,734	3,712,446
Operating Activities:
Net cash provided (used) by operating activities	108,589	(18,355)
Investing Activities:
Property, plant and equipment acquired	(8,103)	(22,258)
Proceeds from sale of property, plant and equipment	9,167	756
Other investing activities, net	122	141
Net cash provided (used) by investing activities	1,186	(21,361)
Financing Activities:
Common stock issued	0	273
Dividends paid	(997)	(19,489)
Treasury stock purchased	0	(50,000)
Repayments of term loan	(4,687)	0
Payments on credit agreement	(58,600)	0
Repayments of short term debt	(1,507)	0
Payments of Financing Costs	(1,011)	0
Other financing activities, net	0	440
Net cash used by financing activities	(66,802)	(68,776)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(5,925)	(9,373)
Increase (Decrease) in Cash and Cash Equivalents	37,048	(117,865)
Cash and Cash Equivalents at Beginning of Period	102,885	270,191	270,191
Cash and Cash Equivalents at End of Period	139,933	152,326	102,885
Parent Company
Condensed Consolidating Statement of Income
Net sales	0	0
Cost of sales	0	(3,177)
Product development, selling and administrative expenses	7,380	11,792
Costs incurred	395	0
Other (income) expense, net	0	0
Operating (loss) income	(7,775)	(8,615)
Intercompany items	15,148	16,770
Interest (expense) income, net	(12,720)	(15,598)
(Loss) income before income taxes	(5,347)	(7,443)
Provision (benefit) for income taxes	(11,505)	20,313
Equity in income of subsidiaries	(46,379)	58,281
Net (loss) income	(40,221)	30,525
Comprehensive loss	(72,584)	(86,474)
Current assets:
Cash and cash equivalents	581	54,874	54,874	21,242	581	10,550	54,874
Accounts receivable, net				0	0
Inventories				0	0
Other current assets				24,035	58,441
Total current assets				45,277	59,022
Property, plant and equipment, net				20,632	21,318
Other assets:
Other intangible assets, net				0	0
Goodwill				0	0
Deferred income taxes				92,648	49,660
Other non-current assets				2,591,311	2,740,518
Total other assets				2,683,959	2,790,178
Total assets				2,749,868	2,870,518
Current liabilities:
Short-term borrowings, including current portion of long-term obligations				23,438	18,750
Trade accounts payable				3,059	3,342
Employee compensation and benefits				8,251	5,843
Advance payments and progress billings				0	0
Accrued warranties				0	0
Other accrued liabilities				86,823	76,650
Current liabilities of discontinued operations				0	0
Total current liabilities				121,571	104,585
Long-term obligations				992,732	1,060,598
Other liabilities:
Liabilities for postretirement benefits				17,296	18,662
Accrued pension costs				178,513	159,594
Other non-current liabilities				95,338	81,595
Total other liabilities				291,147	259,851
Shareholders’ equity				1,344,418	1,445,484
Total liabilities and shareholders’ equity				2,749,868	2,870,518
Operating Activities:
Net cash provided (used) by operating activities	86,203	25,892
Investing Activities:
Property, plant and equipment acquired	(240)	(93)
Proceeds from sale of property, plant and equipment	0	0
Other investing activities, net	(7)	(1,168)
Net cash provided (used) by investing activities	(247)	(1,261)
Financing Activities:
Common stock issued		273
Dividends paid	(997)	(19,489)
Treasury stock purchased		(50,000)
Repayments of term loan	(4,687)
Payments on credit agreement	(58,600)
Repayments of short term debt	0
Payments of Financing Costs	(1,011)
Other financing activities, net		261
Net cash used by financing activities	(65,295)	(68,955)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0	0
Increase (Decrease) in Cash and Cash Equivalents	20,661	(44,324)
Cash and Cash Equivalents at Beginning of Period	581	54,874	54,874
Cash and Cash Equivalents at End of Period	21,242	10,550	581
Subsidiary Guarantors
Condensed Consolidating Statement of Income
Net sales	263,598	439,592
Cost of sales	233,004	319,552
Product development, selling and administrative expenses	40,679	49,377
Costs incurred	20,016	219
Other (income) expense, net	(694)	4,640
Operating (loss) income	(29,407)	65,804
Intercompany items	(47,734)	(23,708)
Interest (expense) income, net	235	1,689
(Loss) income before income taxes	(76,906)	43,785
Provision (benefit) for income taxes	412	3,010
Equity in income of subsidiaries	17,897	1,634
Net (loss) income	(59,421)	42,409
Comprehensive loss	(60,701)	41,000
Current assets:
Cash and cash equivalents	2,008	16,429	16,429	2,187	2,008	3,427	16,429
Accounts receivable, net				176,541	214,381
Inventories				476,511	508,774
Other current assets				15,279	15,610
Total current assets				670,518	740,773
Property, plant and equipment, net				278,543	297,476
Other assets:
Other intangible assets, net				203,219	207,891
Goodwill				346,348	346,348
Deferred income taxes				0	0
Other non-current assets				2,021,610	2,078,294
Total other assets				2,571,177	2,632,533
Total assets				3,520,238	3,670,782
Current liabilities:
Short-term borrowings, including current portion of long-term obligations				0	0
Trade accounts payable				78,021	96,891
Employee compensation and benefits				28,410	36,527
Advance payments and progress billings				100,930	100,312
Accrued warranties				19,521	19,027
Other accrued liabilities				57,052	60,228
Current liabilities of discontinued operations				11,582	11,582
Total current liabilities				295,516	324,567
Long-term obligations				0	0
Other liabilities:
Liabilities for postretirement benefits				0	878
Accrued pension costs				0	8,406
Other non-current liabilities				8,068	8,325
Total other liabilities				8,068	17,609
Shareholders’ equity				3,216,654	3,328,606
Total liabilities and shareholders’ equity				3,520,238	3,670,782
Operating Activities:
Net cash provided (used) by operating activities	(4,944)	(7,426)
Investing Activities:
Property, plant and equipment acquired	(1,666)	(5,971)
Proceeds from sale of property, plant and equipment	6,789	133
Other investing activities, net	0	0
Net cash provided (used) by investing activities	5,123	(5,838)
Financing Activities:
Common stock issued		0
Dividends paid	0	0
Treasury stock purchased		0
Repayments of term loan	0
Payments on credit agreement	0
Repayments of short term debt	0
Payments of Financing Costs	0
Other financing activities, net		262
Net cash used by financing activities	0	262
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0	0
Increase (Decrease) in Cash and Cash Equivalents	179	(13,002)
Cash and Cash Equivalents at Beginning of Period	2,008	16,429	16,429
Cash and Cash Equivalents at End of Period	2,187	3,427	2,008
Non-Guarantor Subsidiaries
Condensed Consolidating Statement of Income
Net sales	390,749	474,572
Cost of sales	309,335	364,592
Product development, selling and administrative expenses	62,354	69,225
Costs incurred	6,248	446
Other (income) expense, net	(3,247)	(7,853)
Operating (loss) income	16,059	48,162
Intercompany items	(6,071)	(6,040)
Interest (expense) income, net	369	952
(Loss) income before income taxes	10,357	43,074
Provision (benefit) for income taxes	(5,889)	(8,347)
Equity in income of subsidiaries	0	0
Net (loss) income	16,246	51,421
Comprehensive loss	(15,030)	(62,663)
Current assets:
Cash and cash equivalents	100,296	198,888	198,888	116,504	100,296	138,349	198,888
Accounts receivable, net				486,316	597,826
Inventories				574,469	607,461
Other current assets				71,565	71,508
Total current assets				1,248,854	1,377,091
Property, plant and equipment, net				458,289	478,253
Other assets:
Other intangible assets, net				46,459	47,819
Goodwill				8,279	8,273
Deferred income taxes				56,993	69,253
Other non-current assets				1,713,911	2,517,110
Total other assets				1,825,642	2,642,455
Total assets				3,532,785	4,497,799
Current liabilities:
Short-term borrowings, including current portion of long-term obligations				6,094	7,571
Trade accounts payable				135,328	175,556
Employee compensation and benefits				42,082	47,965
Advance payments and progress billings				148,901	149,795
Accrued warranties				30,997	33,119
Other accrued liabilities				78,348	100,660
Current liabilities of discontinued operations				0	0
Total current liabilities				441,750	514,666
Long-term obligations				8	45
Other liabilities:
Liabilities for postretirement benefits				0	0
Accrued pension costs				0	7,699
Other non-current liabilities				10,702	35,715
Total other liabilities				10,702	43,414
Shareholders’ equity				3,080,325	3,939,674
Total liabilities and shareholders’ equity				3,532,785	4,497,799
Operating Activities:
Net cash provided (used) by operating activities	27,330	(36,821)
Investing Activities:
Property, plant and equipment acquired	(6,197)	(16,194)
Proceeds from sale of property, plant and equipment	2,378	623
Other investing activities, net	129	1,309
Net cash provided (used) by investing activities	(3,690)	(14,262)
Financing Activities:
Common stock issued		0
Dividends paid	0	0
Treasury stock purchased		0
Repayments of term loan	0
Payments on credit agreement	0
Repayments of short term debt	(1,507)
Payments of Financing Costs	0
Other financing activities, net		(83)
Net cash used by financing activities	(1,507)	(83)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(5,925)	(9,373)
Increase (Decrease) in Cash and Cash Equivalents	16,208	(60,539)
Cash and Cash Equivalents at Beginning of Period	100,296	198,888	198,888
Cash and Cash Equivalents at End of Period	116,504	138,349	100,296
Eliminations
Condensed Consolidating Statement of Income
Net sales	(128,047)	(210,291)
Cost of sales	(104,083)	(163,398)
Product development, selling and administrative expenses	0	0
Costs incurred	0	0
Other (income) expense, net	0	0
Operating (loss) income	(23,964)	(46,893)
Intercompany items	38,657	12,978
Interest (expense) income, net	0	0
(Loss) income before income taxes	14,693	(33,915)
Provision (benefit) for income taxes	0	0
Equity in income of subsidiaries	28,482	(59,915)
Net (loss) income	43,175	(93,830)
Comprehensive loss	75,731	21,663
Current assets:
Cash and cash equivalents	0		0	0	0
Accounts receivable, net				(11,926)	(134)
Inventories				(88,317)	(108,310)
Other current assets				0	0
Total current assets				(100,243)	(108,444)
Property, plant and equipment, net				(5,016)	(5,015)
Other assets:
Other intangible assets, net				0	0
Goodwill				0	0
Deferred income taxes				0	0
Other non-current assets				(6,216,898)	(7,213,194)
Total other assets				(6,216,898)	(7,213,194)
Total assets				(6,322,157)	(7,326,653)
Current liabilities:
Short-term borrowings, including current portion of long-term obligations				0	0
Trade accounts payable				0	0
Employee compensation and benefits				0	0
Advance payments and progress billings				(14,323)	(20,637)
Accrued warranties				0	0
Other accrued liabilities				(10,855)	(12,261)
Current liabilities of discontinued operations				0	0
Total current liabilities				(25,178)	(32,898)
Long-term obligations				0	0
Other liabilities:
Liabilities for postretirement benefits				0	0
Accrued pension costs				0	0
Other non-current liabilities				0	0
Total other liabilities				0	0
Shareholders’ equity				(6,296,979)	(7,293,755)
Total liabilities and shareholders’ equity				(6,322,157)	(7,326,653)
Financing Activities:
Cash and Cash Equivalents at Beginning of Period	0
Cash and Cash Equivalents at End of Period	0		0
Consolidated
Condensed Consolidating Statement of Income
Net sales	526,300	703,873
Cost of sales	438,256	517,569
Product development, selling and administrative expenses	110,413	130,394
Costs incurred	26,659	665
Other (income) expense, net	(3,941)	(3,213)
Operating (loss) income	(45,087)	58,458
Intercompany items	0	0
Interest (expense) income, net	(12,116)	(12,957)
(Loss) income before income taxes	(57,203)	45,501
Provision (benefit) for income taxes	(16,982)	14,976
Equity in income of subsidiaries	0	0
Net (loss) income	(40,221)	30,525
Comprehensive loss	(72,584)	(86,474)
Current assets:
Cash and cash equivalents	102,885	270,191	270,191	139,933	102,885	$ 152,326	$ 270,191
Accounts receivable, net				650,931	812,073
Inventories				962,663	1,007,925
Other current assets				110,879	145,559
Total current assets				1,864,406	2,068,442
Property, plant and equipment, net				752,448	792,032
Other assets:
Other intangible assets, net				249,678	255,710
Goodwill				354,627	354,621
Deferred income taxes				149,641	118,913
Other non-current assets				109,934	122,728
Total other assets				863,880	851,972
Total assets				3,480,734	3,712,446
Current liabilities:
Short-term borrowings, including current portion of long-term obligations				29,532	26,321
Trade accounts payable				216,408	275,789
Employee compensation and benefits				78,743	90,335
Advance payments and progress billings				235,508	229,470
Accrued warranties				50,518	52,146
Other accrued liabilities				211,368	225,277
Current liabilities of discontinued operations				11,582	11,582
Total current liabilities				833,659	910,920
Long-term obligations				992,740	1,060,643
Other liabilities:
Liabilities for postretirement benefits				17,296	19,540
Accrued pension costs				178,513	175,699
Other non-current liabilities				114,108	125,635
Total other liabilities				309,917	320,874
Shareholders’ equity				1,344,418	1,420,009
Total liabilities and shareholders’ equity				$ 3,480,734	$ 3,712,446
Operating Activities:
Net cash provided (used) by operating activities	108,589	(18,355)
Investing Activities:
Property, plant and equipment acquired	(8,103)	(22,258)
Proceeds from sale of property, plant and equipment	9,167	756
Other investing activities, net	122	141
Net cash provided (used) by investing activities	1,186	(21,361)
Financing Activities:
Common stock issued		273
Dividends paid	(997)	(19,489)
Treasury stock purchased		(50,000)
Repayments of term loan	(4,687)
Payments on credit agreement	(58,600)
Repayments of short term debt	(1,507)
Payments of Financing Costs	(1,011)
Other financing activities, net		440
Net cash used by financing activities	(66,802)	(68,776)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(5,925)	(9,373)
Increase (Decrease) in Cash and Cash Equivalents	37,048	(117,865)
Cash and Cash Equivalents at Beginning of Period	102,885	270,191	270,191
Cash and Cash Equivalents at End of Period	$ 139,933	$ 152,326	$ 102,885